Clarence Colby

1.5k total citations
36 papers, 1.3k citations indexed

About

Clarence Colby is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Clarence Colby has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Immunology. Recurrent topics in Clarence Colby's work include Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (5 papers) and RNA and protein synthesis mechanisms (5 papers). Clarence Colby is often cited by papers focused on Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (5 papers) and RNA and protein synthesis mechanisms (5 papers). Clarence Colby collaborates with scholars based in United States, Israel and Canada. Clarence Colby's co-authors include Peter Duesberg, Michael J. Chamberlin, A Romanò, Gordon Edlin, Joseph R. Kates, Michael J. Morgan, Harvey Bialy, Ankang Hu, Ernest C. Borden and Sidney E. Grossberg and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Clarence Colby

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clarence Colby United States 22 630 305 278 192 160 36 1.3k
Hiroshi Amanuma Japan 21 852 1.4× 304 1.0× 523 1.9× 101 0.5× 205 1.3× 67 1.6k
Kira K. Lueders United States 27 1.7k 2.7× 296 1.0× 506 1.8× 91 0.5× 180 1.1× 58 2.3k
Ronald Mertz Germany 13 808 1.3× 85 0.3× 204 0.7× 78 0.4× 207 1.3× 13 1.1k
D Stueber Switzerland 10 858 1.4× 403 1.3× 337 1.2× 88 0.5× 91 0.6× 11 1.4k
S S Sommer United States 10 1.3k 2.0× 101 0.3× 309 1.1× 88 0.5× 120 0.8× 11 1.7k
Lana Schaffer United States 23 1.1k 1.7× 429 1.4× 175 0.6× 186 1.0× 154 1.0× 43 1.7k
Henry Lackland United States 19 952 1.5× 212 0.7× 165 0.6× 364 1.9× 148 0.9× 33 2.2k
Katsuyuki Hashimoto Japan 21 918 1.5× 178 0.6× 350 1.3× 211 1.1× 165 1.0× 77 1.7k
Yuji Hidaka Japan 26 1.1k 1.8× 223 0.7× 300 1.1× 311 1.6× 143 0.9× 79 1.8k
Nicholas M. Stamatos United States 19 658 1.0× 385 1.3× 96 0.3× 114 0.6× 98 0.6× 23 1.1k

Countries citing papers authored by Clarence Colby

Since Specialization
Citations

This map shows the geographic impact of Clarence Colby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarence Colby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarence Colby more than expected).

Fields of papers citing papers by Clarence Colby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarence Colby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarence Colby. The network helps show where Clarence Colby may publish in the future.

Co-authorship network of co-authors of Clarence Colby

This figure shows the co-authorship network connecting the top 25 collaborators of Clarence Colby. A scholar is included among the top collaborators of Clarence Colby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarence Colby. Clarence Colby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biernacka, Joanna M., Kristen Snyder, Linda L. Pelleymounter, et al.. (2010). Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response. The Pharmacogenomics Journal. 12(1). 78–85. 28 indexed citations
2.
Colby, Clarence & Scott M. Williams. (1995). The effect of adaptive mutagenesis on genetic variation at a linked, neutral locus.. Genetics. 140(3). 1129–1136. 4 indexed citations
3.
Witt, Patricia L., Barry E. Storer, George T. Bryan, et al.. (1993). Pharmacodynamics of Biological Response In Vivo After Single and Multiple Doses of Interferon?????. Journal of Immunotherapy. 13(3). 191–200. 57 indexed citations
4.
Witt, Patricia L., Daniel A. Goldstein, Barry E. Storer, et al.. (1992). Absence of Biological Effects of Orally Administered Interferon-β ser. Journal of Interferon Research. 12(6). 411–413. 36 indexed citations
5.
Williams, Gary J., Clarence Colby, Raymond F. Schinazi, et al.. (1990). The Cellular Metabolism of AzdU. Annals of the New York Academy of Sciences. 616(1). 620–623. 2 indexed citations
6.
7.
Williams, Gary J. & Clarence Colby. (1989). Recombinant Human Interferon-β Suppresses the Replication of HIV and Acts Synergistically with AZT. Journal of Interferon Research. 9(6). 709–718. 11 indexed citations
8.
Mory, Y, Yuti Chernajovsky, Sheldon I. Feinstein, et al.. (1981). Synthesis of Human Interferon β1 in Escherichia coliInfected by a Lambda Phage Recombinant containing a Human Genomic Fragment. European Journal of Biochemistry. 120(1). 197–202. 36 indexed citations
9.
Colby, Clarence, Edward E. Penhoet, & Charles E. Samuel. (1976). A comparison of transfer RNA from untreated and interferon-treated murine cells. Virology. 74(1). 262–264. 19 indexed citations
10.
Hassell, John A., Clarence Colby, & Antonio H. Romano. (1975). The effect of serum on the transport and phosphorylation of 2‐deoxyglucose by untransformed and transformed mouse 3T3 cells. Journal of Cellular Physiology. 86(1). 37–45. 18 indexed citations
11.
Radke, Kathryn, Clarence Colby, Joseph R. Kates, Hallie M. Krider, & David M. Prescott. (1974). Establishment and Maintenance of the Interferon-Induced Antiviral State: Studies in Enucleated Cells. Journal of Virology. 13(3). 623–630. 43 indexed citations
12.
Morgan, Michael J., et al.. (1973). Isolation and Characterization of Virus-resistant Mouse Embryo Fibroblasts. Journal of General Virology. 20(3). 377–385. 14 indexed citations
13.
Bialy, Harvey & Clarence Colby. (1972). Inhibition of Early Vaccinia Virus Ribonucleic Acid Synthesis in Interferon-Treated Chicken Embryo Fibroblasts. Journal of Virology. 9(2). 286–289. 43 indexed citations
14.
Colby, Clarence, et al.. (1971). Mechanism of Synthesis of Vaccinia Virus Double-Stranded Ribonucleic Acid In Vivo and In Vitro. Journal of Virology. 7(1). 71–76. 70 indexed citations
15.
Colby, Clarence, B. David Stollar, & Melvin I. Simon. (1971). Interferon Induction: DNA–RNA Hybrid or Double Stranded RNA?. Nature New Biology. 229(6). 172–174. 32 indexed citations
16.
Kates, Joseph R., et al.. (1970). Isolation of Double-stranded RNA from T4 Phage Infected Cells. Nature. 226(5250). 1027–1029. 24 indexed citations
17.
Colby, Clarence & Harry Rubin. (1969). Growth and Nucleic Acid Synthesis in Normal Cells and Cells Infected With Rous Sarcoma Virus<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 43(2). 437–44. 24 indexed citations
18.
Colby, Clarence & Peter Duesberg. (1969). Double-stranded RNA in Vaccinia Virus Infected Cells. Nature. 222(5197). 940–944. 156 indexed citations
19.
Rubin, H. B. & Clarence Colby. (1968). Early release of growth inhibition in cells infected with Rous sarcoma virus.. Proceedings of the National Academy of Sciences. 60(2). 482–488. 22 indexed citations
20.
Colby, Clarence & Ankang Hu. (1968). Purification and comparison of the β-galactosidase synthesized by Escherichia coli F-lac+ and Proteus mirabilis F-lac+. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 157(1). 167–177. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Amanuma Breakdown of academic impact, for papers by Kira K. Lueders Breakdown of academic impact, for papers by Ronald Mertz Breakdown of academic impact, for papers by D Stueber Breakdown of academic impact, for papers by S S Sommer Breakdown of academic impact, for papers by Lana Schaffer Breakdown of academic impact, for papers by Henry Lackland Breakdown of academic impact, for papers by Katsuyuki Hashimoto Breakdown of academic impact, for papers by Yuji Hidaka Breakdown of academic impact, for papers by Nicholas M. Stamatos
Rankless by CCL
2026